| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777448A Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| 05/24/2006 | CN1777442A Modified live vaccines comprising BHV-1(IBR) and/or BVDV for pregnant and nursing cattles |
| 05/24/2006 | CN1777415A Medicinal composition containing edible acid or its acid salt and its use |
| 05/24/2006 | CN1777414A Glycinamide derivative for inhibiting HIV replication |
| 05/24/2006 | CN1777363A Ss-l-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 05/24/2006 | CN1775802A Human papillomavirus immunogenic polypeptide, and its preparing method and use |
| 05/24/2006 | CN1775798A Method for producing high-purity chenodeoxy cholic acid from poultry and livestock bile |
| 05/24/2006 | CN1775723A Bromo-2, 4'-dihydroxy diphenyl ether compound and its synthesizing method |
| 05/24/2006 | CN1775287A SARS influenza bivalent combined vaccine and its preparing process |
| 05/24/2006 | CN1775242A Medicine composition with bacteria-inhibiting anti-inflammation function, its preparing method and use |
| 05/24/2006 | CN1775228A Method for preparing Chinese medicine for antibacterial and anti-inflammation and its quality control technology |
| 05/24/2006 | CN1775220A Use of malposed double-strauded oligo nucleotide for preparing medicine for treating avian flu virus infection |
| 05/24/2006 | CN1775217A Medicinal composition for treating Heptitis B |
| 05/24/2006 | CN1775214A Rifapentine, refampicin, rifabutin or rifamdin injection and its preparing method |
| 05/24/2006 | CN1775210A Ftibamzone eyedrops |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1257284C Method of blocking expression of hepatitis B virus |
| 05/24/2006 | CN1257186C Interferon gamma polypeptide variants |
| 05/24/2006 | CN1257175C Adefovir dipivoxil new crystal state, new crystal state composition and its preparing method |
| 05/24/2006 | CN1257164C Aromatic amides, preparation method and application as medicines |
| 05/24/2006 | CN1257162C SARS coronavirus 3CL protease inhibitor and its use |
| 05/24/2006 | CN1256982C Combinations of dalfopristine/quinupristine with cefpirome |
| 05/24/2006 | CN1256979C Traditional Chinese medicinal prepn. capsule for treating presistent febris during common cold |
| 05/24/2006 | CN1256975C Anti-virus compound Chinese medicine and its preparing method |
| 05/24/2006 | CN1256964C Externally used yang-strengthening liquor capable of resisting human immunodeficiency virus and its preparation |
| 05/24/2006 | CN1256905C New method for inhibiting flu and preventing SARS |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049431 Antisense antibacterial cell division composition and method |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049417 6,11-4-Carbon bridged ketolides |
| 05/23/2006 | US7049415 Pegylated T20 polypeptide |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049394 Method for preparing free flow resin |
| 05/23/2006 | US7049338 Antiproliferative agents |
| 05/23/2006 | US7049332 Effective against mutations; such as 2,3-Dihydro-4-ethyl-1-(3-methylphenylamino)-5-phenyl-1H-imidazole-2-thione |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049315 Solubilized topoisomerase poisons |
| 05/23/2006 | US7049311 Pyrrolbenzodiazepines |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049303 Inhibition of viruses |
| 05/23/2006 | US7049295 Compounds and use thereof to modify transport across cell membranes |
| 05/23/2006 | US7049117 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/23/2006 | US7048950 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations |
| 05/23/2006 | US7048946 Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agents |
| 05/23/2006 | US7048937 Methods and compositions for control of coccidiosis |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048924 Combination antiviral and interleukin-2 therapy for HIV infection |
| 05/23/2006 | US7048913 Antifungal composition and method for human nails |
| 05/23/2006 | US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2411766C Non-nucleoside reverse transcriptase inhibitors |
| 05/23/2006 | CA2261619C Nucleotide analogs |
| 05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
| 05/18/2006 | WO2006053170A1 Sugars and/or sugar alcohols for inhibiting and/or treating vaginal infection |
| 05/18/2006 | WO2006052930A1 Antimicrobial 2-deoxystreptamine compounds |
| 05/18/2006 | WO2006052499A1 Capreomycin derivatives and their use as antibacterials |
| 05/18/2006 | WO2006052201A1 Use of derivatives of dipeptides for the manufacture of a medicament for the treatment of microbial infections |
| 05/18/2006 | WO2006052013A1 Thienopyrrole compounds and utilization thereof as hcv polymerase inhibitor |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051805A1 MUTANT INTERFERON α PROTEINS AND USE THEREOF |
| 05/18/2006 | WO2006051408A1 Oxazolidinone derivatives as antimicrobials |
| 05/18/2006 | WO2006051091A1 Compositions against sars-coronavirus and uses thereof |
| 05/18/2006 | WO2006050943A1 Macrolone compounds |
| 05/18/2006 | WO2006050942A1 Macrolones - amino substituted quinolones |
| 05/18/2006 | WO2006050941A1 Macrolone compounds |
| 05/18/2006 | WO2006050940A1 Macrolone compounds |
| 05/18/2006 | WO2006050930A2 Conjugates with enhanced cell uptake activity |
| 05/18/2006 | WO2006050611A1 Antimicrobial peptides |
| 05/18/2006 | WO2006021888B1 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 05/18/2006 | WO2006020071A3 Vaccines against aids comprising cmv/r-nucleic acid constructs |
| 05/18/2006 | WO2005102309A3 In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration |
| 05/18/2006 | WO2005009451A9 Bacteriophage-containing therapeutic agents |
| 05/18/2006 | US20060107339 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106052 Method of using sulfonamide substituted imidazoquinolines |
| 05/18/2006 | US20060106044 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/18/2006 | US20060106019 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 05/18/2006 | US20060105990 Uronic acid-terminated carbohydrate having a double bond between the C4 and C5 atom of the uronic acid a maximum degree of polymerization of 100, combined with a mixture of two different undigestable prebiotic carbohydrates; blocking the adhesion of pathogens or toxins to eucariotic cells |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105983 Cytotoxic agents |
| 05/18/2006 | US20060105968 Compositions comprising highly purified amphotericin b |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105946 Method for treating the central nervous system by administration of igf structural analogs |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104985 Dengue virus infection inhibitor |
| 05/18/2006 | US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 05/18/2006 | US20060104956 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer |
| 05/18/2006 | US20060104935 Controlled dissolution crosslinked protein crystals |